Unicycive Therapeutics, Inc. (UNCY) Q1 2026 Earnings
UNCY·Reported May 12, 2026·Before market open
Diluted EPS came in at $-0.54 (-107.7% YoY), missed the $-0.46 consensus by $0.08.
Diluted EPS
$-0.54missed by $0.08
Consensus: $-0.46
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Unicycive Therapeutics, Inc.'s Q1 2026 earnings report.
Unicycive Therapeutics, Inc. (UNCY) reported Q1 2026 earnings on May 12, 2026 before market open.
Unicycive Therapeutics, Inc. reported diluted EPS of $-0.54 for Q1 2026.
EPS missed the consensus estimate of $-0.46 by $0.08.
Compared to the same quarter a year prior, diluted EPS declined 107.7% from $-0.26.
You can read the 8-K earnings release (0001213900-26-054736) and the 10-Q periodic report (0001213900-26-054708) directly on SEC EDGAR. The filing index links above go to sec.gov.